Found: 147
Select item for more details and to access through your institution.
Phase I study of S-1 plus paclitaxel combination therapy as a first-line treatment in elderly patients with advanced non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 2, p. 291, doi. 10.1007/s10637-018-0656-z
- By:
- Publication type:
- Article
Nab-paclitaxel maintenance therapy following carboplatin + nab-paclitaxel combination therapy in chemotherapy naïve patients with advanced non-small cell lung cancer: multicenter, open-label, single-arm phase II trial.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 5, p. 903, doi. 10.1007/s10637-018-0617-6
- By:
- Publication type:
- Article
Severe acute interstitial lung disease in a patient with anaplastic lymphoma kinase rearrangement-positive non-small cell lung cancer treated with alectinib.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 5, p. 1148, doi. 10.1007/s10637-015-0284-9
- By:
- Publication type:
- Article
Infected complex renal cysts during crizotinib therapy in a patient with non-small cell lung cancer positive for ALK rearrangement.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 2, p. 510, doi. 10.1007/s10637-014-0195-1
- By:
- Publication type:
- Article
G-CSF increases secretion of urokinase-typeplasminogen activator by human lung cancer cells.
- Published in:
- Clinical & Experimental Metastasis, 1998, v. 16, n. 6, p. 551, doi. 10.1023/A:1006546402703
- By:
- Publication type:
- Article
Inter-patient variation in efficacy of five oncolytic adenovirus candidates for ovarian cancer therapy.
- Published in:
- Journal of Gene Medicine, 2004, v. 6, n. 12, p. 1333, doi. 10.1002/jgm.635
- By:
- Publication type:
- Article
Evaluation of tissue-specific promoters in carcinomas of the cervix uteri.
- Published in:
- Journal of Gene Medicine, 2004, v. 6, n. 11, p. 1281, doi. 10.1002/jgm.606
- By:
- Publication type:
- Article
TARC and RANTES enhance antitumor immunity induced by the GM-CSF-transduced tumor vaccine in a mouse tumor model.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 9, p. 1399, doi. 10.1007/s00262-008-0476-7
- By:
- Publication type:
- Article
Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas.
- Published in:
- International Journal of Cancer, 2006, v. 119, n. 6, p. 1303, doi. 10.1002/ijc.22006
- By:
- Publication type:
- Article
Polycyclic Aromatic Hydrocarbon Carcinogens Increase Ubiquitination of p21 Protein after the Stabilization of p53 and the Expression of p21.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2000, v. 22, n. 6, p. 747, doi. 10.1165/ajrcmb.22.6.3877
- By:
- Publication type:
- Article
Variability of serum CYFRA 21 − 1 and its susceptibility to clinical characteristics in individuals without cancer: a 4-year retrospective analysis.
- Published in:
- BMC Pulmonary Medicine, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12890-023-02650-x
- By:
- Publication type:
- Article
The Impact of VEGF Inhibition on Clinical Outcomes in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy: A Retrospective Cohort Study.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.663612
- By:
- Publication type:
- Article
Immune-Related Adverse Events Are Associated With Clinical Benefit in Patients With Non-Small-Cell Lung Cancer Treated With Immunotherapy Plus Chemotherapy: A Retrospective Study.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.630136
- By:
- Publication type:
- Article
Recurrence of Large-Vessel Vasculitis Induced by Multiple Types of Granulocyte Colony-Stimulating Factor Preparation in Patient with Large-Cell Neuroendocrine Lung Carcinoma: A Case Report.
- Published in:
- Case Reports in Oncology, 2023, v. 16, n. 1, p. 771, doi. 10.1159/000533375
- By:
- Publication type:
- Article
Late-onset Pleural and Pericardial Effusion as Immune-related Adverse Events after 94 Cycles of Nivolumab.
- Published in:
- Internal Medicine, 2021, v. 60, n. 22, p. 3585, doi. 10.2169/internalmedicine.7219-21
- By:
- Publication type:
- Article
Prognosis of Bronchial Artery Embolization in the Management of Hemoptysis.
- Published in:
- Respiration, 2000, v. 67, n. 4, p. 412, doi. 10.1159/000029540
- By:
- Publication type:
- Article
Comparison of Alveolar Septal Inflammation to Bronchoalveolar Lavage in Interstitial Lung Diseases.
- Published in:
- Respiration, 1996, v. 63, n. 2, p. 94, doi. 10.1159/000196525
- By:
- Publication type:
- Article
Risk Factors for Predicting Severe Neutropenia Induced by Amrubicin in Patients with Advanced Lung Cancer.
- Published in:
- Chemotherapy (0009-3157), 2013, v. 58, n. 6, p. 419, doi. 10.1159/000345617
- By:
- Publication type:
- Article
Phase I Study of Weekly Irinotecan Combined with Weekly Cisplatin in Patients with Advanced Solid Tumors.
- Published in:
- Chemotherapy (0009-3157), 2002, v. 48, n. 4, p. 205, doi. 10.1159/000063866
- By:
- Publication type:
- Article
Histone deacetylase inhibitor OBP-801 and amrubicin synergistically inhibit the growth of squamous cell lung carcinoma by inducing mitochondrial ASK1-dependent apoptosis.
- Published in:
- International Journal of Oncology, 2020, v. 56, n. 3, p. 848, doi. 10.3892/ijo.2020.4969
- By:
- Publication type:
- Article
Lung Cancer Risk and Genetic Polymorphisms in DNA Repair Pathways: AMeta-Analysis.
- Published in:
- Journal of Nucleic Acids, 2010, p. 1, doi. 10.4061/2010/701760
- By:
- Publication type:
- Article
Rationale and design of phase II clinical trial of dual inhibition with ramucirumab and erlotinib in EGFR exon 19 deletion-positive treatment-naïve non-small cell lung cancer with high PD-L1 expression (SPIRAL-3D study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231177022
- By:
- Publication type:
- Article
Epithelial-mesenchymal transition status is a remarkable biomarker for the combination treatment with avutometinib and defactinib in KRAS-mutated non-small cell lung cancer.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 2, p. 361, doi. 10.1038/s41416-024-02727-2
- By:
- Publication type:
- Article
The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Predictors for the Development of Thromboembolic Events in Cancer Patients Treated with Bevacizumab, Ramucirumab, and Aflibercept: A Single-Institution Retrospective Analysis.
- Published in:
- Oncology, 2024, v. 102, n. 7, p. 604, doi. 10.1159/000536187
- By:
- Publication type:
- Article
Risk Factors of Capecitabine-Induced Hand-Foot Syndrome: A Single-Institution, Retrospective Study.
- Published in:
- Oncology, 2023, v. 101, n. 7, p. 407, doi. 10.1159/000529851
- By:
- Publication type:
- Article
280. RANTES and TARC Enhanced the Antitumor Immune Effects of GM-CSF.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S107, doi. 10.1016/j.ymthe.2006.08.334
- By:
- Publication type:
- Article
364. Prevention of Radiation Pneumonitis by Recombinant Adenovirus-Mediated Transfer of Soluble TGF-βtype II Receptor Gene
- Published in:
- 2005
- By:
- Publication type:
- Abstract
322. Tumor Specific Activation of Irinotecan by a Carboxylesterase Fused with Anti CEA scFv
- Published in:
- 2005
- By:
- Publication type:
- Abstract
154. Relationship between the Expression of Membrane Receptors (CAR, Integrin αvβ3 and Integrin αvβ5 ) and Adenoviral Transduction Efficiency
- Published in:
- 2005
- By:
- Publication type:
- Abstract
Safety and tolerability of PD-1/PD-L1 inhibitors in elderly and frail patients with advanced malignancies.
- Published in:
- Oncology Letters, 2020, v. 20, n. 4, p. N.PAG
- By:
- Publication type:
- Article
Clinical features of immune-related thyroid dysfunction and its association with outcomes in patients with advanced malignancies treated by PD-1 blockade.
- Published in:
- Oncology Letters, 2019, v. 18, n. 2, p. 2140, doi. 10.3892/ol.2019.10466
- By:
- Publication type:
- Article
Prospective analysis of the association between skeletal-related events and quality of life in patients with advanced lung cancer (CSP-HOR13).
- Published in:
- Oncology Letters, 2019, v. 17, n. 1, p. 1320
- By:
- Publication type:
- Article
Measurement of exhaled nitric oxide and serum surfactant protein D levels for monitoring radiation pneumonitis following thoracic radiotherapy.
- Published in:
- Oncology Letters, 2017, v. 14, n. 4, p. 4190, doi. 10.3892/ol.2017.6691
- By:
- Publication type:
- Article
Epidemiology, risk factors and impact of cachexia on patient outcome: Results from the Japanese Lung Cancer Registry Study.
- Published in:
- Journal of Cachexia, Sarcopenia & Muscle, 2023, v. 14, n. 3, p. 1274, doi. 10.1002/jcsm.13216
- By:
- Publication type:
- Article
Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non‐small‐cell lung cancer.
- Published in:
- Journal of Cachexia, Sarcopenia & Muscle, 2019, v. 10, n. 1, p. 73, doi. 10.1002/jcsm.12351
- By:
- Publication type:
- Article
Predictors for development of oxaliplatin-induced peripheral neuropathy in cancer patients as determined by ordered logistic regression analysis.
- Published in:
- PLoS ONE, 2022, v. 17, n. 9, p. 1, doi. 10.1371/journal.pone.0275481
- By:
- Publication type:
- Article
Infectivity enhanced, hTERT promoter-based conditionally replicative adenoviruses are useful for SCLC treatment.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 9, p. 737, doi. 10.1038/sj.cgt.7700838
- By:
- Publication type:
- Article
Anti-tumor angiogenesis therapy using soluble receptors: enhanced inhibition of tumor growth when soluble fibroblast growth factor receptor-1 is used with soluble vascular endothelial growth factor receptor.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 8, p. 633, doi. 10.1038/sj.cgt.7700478
- By:
- Publication type:
- Article
Alteration of drug chemosensitivity caused by the adenovirus-mediated transfer of the wild-type p53 gene in human lung cancer cells.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 2, p. 300, doi. 10.1038/sj.cgt.7700096
- By:
- Publication type:
- Article
Impact of maintenance therapy following induction immunochemotherapy for untreated advanced non-small cell lung cancer patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 11, p. 2985, doi. 10.1007/s00432-021-03866-2
- By:
- Publication type:
- Article
Early discontinuation of induction therapy in chemoimmunotherapy as an effective alternative to the standard regimen in patients with non-small cell lung cancer: a retrospective study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 9, p. 2437, doi. 10.1007/s00432-021-03782-5
- By:
- Publication type:
- Article
Pleomorphic rhabdomyosarcoma in a young adult harboring a novel germline MSH2 variant.
- Published in:
- Human Genome Variation, 2022, v. 9, n. 1, p. 1, doi. 10.1038/s41439-022-00185-x
- By:
- Publication type:
- Article
Prospective Observational Study of Ramucirumab Plus Docetaxel After Combined Chemoimmunotherapy in Patients With Non‐Small‐Cell Lung Cancer.
- Published in:
- Oncologist, 2024, v. 29, n. 5, p. e681, doi. 10.1093/oncolo/oyae001
- By:
- Publication type:
- Article
Ramucirumab Plus Docetaxel for Patients with Non-small cell Lung Cancer with Brain Metastases: A Multicenter, Open-Label Single-Arm Phase II Trial.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. 551, doi. 10.1093/oncolo/oyad013
- By:
- Publication type:
- Article
Randomized Phase II Study of First‐Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untreated Non‐Small Cell Lung Cancer: LOGIK0801.
- Published in:
- Oncologist, 2020, v. 25, n. 8, p. e1146, doi. 10.1634/theoncologist.2020-0322
- By:
- Publication type:
- Article
Phase II Study on Biweekly Combination Therapy of Gemcitabine plus Carboplatin for the Treatment of Elderly Patients with Advanced Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. 208, doi. 10.1634/theoncologist.2019-0717
- By:
- Publication type:
- Article
Randomized Phase II Study of Weekly Paclitaxel plus Carboplatin Versus Biweekly Paclitaxel plus Carboplatin for Patients with Previously Untreated Advanced Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1420, doi. 10.1634/theoncologist.2019-0513
- By:
- Publication type:
- Article
Phase II Study of S‐1 and Paclitaxel Combination Therapy in Patients with Previously Treated Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 8, p. 1033, doi. 10.1634/theoncologist.2019-0290
- By:
- Publication type:
- Article
A Phase II Study of S‐1 and Paclitaxel Combination Therapy as a First‐Line Treatment in Elderly Patients with Advanced Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 459, doi. 10.1634/theoncologist.2018-0858
- By:
- Publication type:
- Article